Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods

• Κύριοι συγγραφείς: Tiziana Ginex (Συγγραφέας), Urtzi Garaigorta (Συγγραφέας), David Ramírez (Συγγραφέας), Victoria Castro (Συγγραφέας), Vanesa Nozal (Συγγραφέας), Inés Maestro (Συγγραφέας), Javier García-Cárceles (Συγγραφέας), Nuria E. Campillo (Συγγραφέας), Ana Martinez (Συγγραφέας), Pablo Gastaminza (Συγγραφέας), Carmen Gil (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: MDPI AG, 2021-04-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

The unprecedent situation generated by the COVID-19 global emergency has prompted us to actively work to fight against this pandemic by searching for repurposable agents among FDA approved drugs to shed light into immediate opportunities for the treatment of COVID-19 patients. In the attempt to proc...